These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 949879)
21. Effect of aspirin on the complement system in vitro. Hänsch GM; Voigtländer V; Rother U Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347 [TBL] [Abstract][Full Text] [Related]
22. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Wager O Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712 [No Abstract] [Full Text] [Related]
25. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1. Thielens NM; Villiers MB; Reboul A; Villiers CL; Colomb MG FEBS Lett; 1982 May; 141(1):19-24. PubMed ID: 6282646 [No Abstract] [Full Text] [Related]
26. Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Agnello V Arthritis Rheum; 1978 Jun; 21(5 Suppl):S146-52. PubMed ID: 666879 [TBL] [Abstract][Full Text] [Related]
27. [Immunoglobulins and complement in systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis]. Dostal Ts; Shusta A; Gana I; Bardfeld R Ter Arkh; 1974; 46(11):98-100. PubMed ID: 4216106 [No Abstract] [Full Text] [Related]
28. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement. Hedberg H; Lundh B; Laurell AB Clin Exp Immunol; 1970 May; 6(5):707-12. PubMed ID: 5477926 [TBL] [Abstract][Full Text] [Related]
29. Clinical significance of synovial fluid total hemolytic complement activity. Kim HJ; McCarty DJ; Kozin F; Koethe S J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616 [TBL] [Abstract][Full Text] [Related]
30. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus. Rosano CL; Parhami N; Hechemy KE; Hurwitz C Inflammation; 1988 Aug; 12(4):351-60. PubMed ID: 3262584 [TBL] [Abstract][Full Text] [Related]
31. Complement and the clinician. Palmer DG Aust N Z J Med; 1976 Aug; 6(4):349-56. PubMed ID: 1070993 [TBL] [Abstract][Full Text] [Related]
32. [Dynamics of the immunological changes in rheumatoid arthritis borderline with systemic lupus erythematosus]. Nasonova VA; Speranskiĭ AI; Astapanko MG; Bulanova TD Vopr Revm; 1978; (1):7-11. PubMed ID: 654199 [No Abstract] [Full Text] [Related]
33. Activation of complement in human nephritis. Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001 [No Abstract] [Full Text] [Related]
34. Studies with human leukocyte lysosomes. Evidence for antilysosome antibodies in lupus erythematosus and for the presence of lysosomal antigen in inflammatory diseases. Bell DA; Thiem PA; Vaughan JH; Leddy JP J Clin Invest; 1975 Feb; 55(2):256-68. PubMed ID: 1092714 [TBL] [Abstract][Full Text] [Related]
35. Appraisal of rheumatoid arthritis as an immune complex disease. Broder I; Urowitz MB; Gordon DA Med Clin North Am; 1972 Mar; 56(2):529-39. PubMed ID: 4111877 [No Abstract] [Full Text] [Related]
36. Anti-nuclear factors in rheumatoid arthritis, systemic lupus erythematosus and other diseases. Re-evaluation of the nucleoprotein complement fixation technique and anti-complementary activity. Onodera S; Schubart AF; Ewald RW; Heuckenkamp PU J Chronic Dis; 1966; 19(11):1133-44. PubMed ID: 5297998 [No Abstract] [Full Text] [Related]